Attention Deficit Disorder with Hyperactivity
"Attention Deficit Disorder with Hyperactivity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A behavior disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood. (From DSM-V)
Descriptor ID |
D001289
|
MeSH Number(s) |
F03.625.094.150
|
Concept/Terms |
Attention Deficit Disorder with Hyperactivity- Attention Deficit Disorder with Hyperactivity
- Attention Deficit Disorders with Hyperactivity
- Attention Deficit Hyperactivity Disorders
- Attention Deficit-Hyperactivity Disorder
- Attention Deficit-Hyperactivity Disorders
- Deficit-Hyperactivity Disorder, Attention
- Deficit-Hyperactivity Disorders, Attention
- Disorder, Attention Deficit-Hyperactivity
- Disorders, Attention Deficit-Hyperactivity
- Hyperkinetic Syndrome
- Syndromes, Hyperkinetic
- ADDH
- Attention Deficit Hyperactivity Disorder
Attention Deficit Disorder- Attention Deficit Disorder
- Attention Deficit Disorders
- Deficit Disorder, Attention
- Deficit Disorders, Attention
- Disorder, Attention Deficit
- Disorders, Attention Deficit
|
Below are MeSH descriptors whose meaning is more general than "Attention Deficit Disorder with Hyperactivity".
Below are MeSH descriptors whose meaning is more specific than "Attention Deficit Disorder with Hyperactivity".
This graph shows the total number of publications written about "Attention Deficit Disorder with Hyperactivity" by people in this website by year, and whether "Attention Deficit Disorder with Hyperactivity" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 1 | 0 | 1 | 2010 | 0 | 1 | 1 | 2016 | 3 | 0 | 3 | 2018 | 1 | 0 | 1 | 2019 | 1 | 0 | 1 | 2020 | 0 | 1 | 1 | 2021 | 3 | 0 | 3 | 2022 | 1 | 0 | 1 | 2024 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Attention Deficit Disorder with Hyperactivity" by people in Profiles.
-
Cheng S, Al-Kofahi M, Leeder JS, Brown JT. Population Pharmacokinetic Analysis of Atomoxetine and its Metabolites in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Clin Pharmacol Ther. 2024 May; 115(5):1033-1043.
-
Loskutova NY, Lutgen C, Smail C, Staton EW, Nichols SD, Pinckney RG. Stimulant Prescribing Error Assessment Rubric Development. J Patient Saf. 2022 01 01; 18(1):e282-e289.
-
Paulus MP, Kuplicki R, Victor TA, Yeh HW, Khalsa SS. Methylphenidate augmentation of escitalopram to enhance adherence to antidepressant treatment: a pilot randomized controlled trial. BMC Psychiatry. 2021 11 19; 21(1):582.
-
Allan CC, DeShazer M, Staggs VS, Nadler C, Crawford TP, Moody S, Chacko A. Accidental Injuries in Preschoolers: Are We Missing an Opportunity for Early Assessment and Intervention? J Pediatr Psychol. 2021 08 11; 46(7):835-843.
-
Tang Girdwood SC, Rossow KM, Van Driest SL, Ramsey LB. Perspectives from the Society for Pediatric Research: pharmacogenetics for pediatricians. Pediatr Res. 2022 02; 91(3):529-538.
-
Roberts TA, Wagner JA, Sandritter T, Black BT, Gaedigk A, Stancil SL. Retrospective Review of Pharmacogenetic Testing at an Academic Children's Hospital. Clin Transl Sci. 2021 01; 14(1):412-421.
-
Wolraich ML, Hagan JF, Allan C, Chan E, Davison D, Earls M, Evans SW, Flinn SK, Froehlich T, Frost J, Holbrook JR, Lehmann CU, Lessin HR, Okechukwu K, Pierce KL, Winner JD, Zurhellen W. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics. 2019 10; 144(4).
-
Brown JT, Bishop JR, Sangkuhl K, Nurmi EL, Mueller DJ, Dinh JC, Gaedigk A, Klein TE, Caudle KE, McCracken JT, de Leon J, Leeder JS. Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy. Clin Pharmacol Ther. 2019 07; 106(1):94-102.
-
Wehry AM, Ramsey L, Dulemba SE, Mossman SA, Strawn JR. Pharmacogenomic Testing in Child and Adolescent Psychiatry: An Evidence-Based Review. Curr Probl Pediatr Adolesc Health Care. 2018 02; 48(2):40-49.
-
Dinh JC, Pearce RE, Van Haandel L, Gaedigk A, Leeder JS. Characterization of Atomoxetine Biotransformation and Implications for Development of PBPK Models for Dose Individualization in Children. Drug Metab Dispos. 2016 07; 44(7):1070-9.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|